Top 10 HK Stock Gainers (5.8)

LongportMay 8, 2026 8:31 AM

View all comments（0）



Hang Seng Index has fell 0.87%, with a year-to-date rose 3%; Hang Seng TECH Index has fell 0.36%, with a year-to-date fell 7.5%.

160 HEALTH(02656) rose 44.26%, with a trading turnover 2.4 Billion HKD, and a year-to-date fell 57.9%.

HAIZHI TECH GP(02706) rose 25.96%, with a trading turnover 363.0 Million HKD, and a year-to-date rose 129.5%.

AIM VACCINE(06660) rose 21.83%, with a trading turnover 10.6 Million HKD, and a year-to-date fell 4.4%.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

U.S. Stocks Hit New Highs as Warsh Takes Office, Nvidia Rises for Seventh Day, Cerebras Surges in Debut

TradingKey - On May 14 (ET), the three major U.S. stock indices closed higher across the board, with both the Nasdaq and the S&P 500 hitting new record highs. The Dow Jones Industrial Average closed above the 50,000 mark for the first time in three months. On the same day, Kevin Warsh officially succeeded Jerome Powell as Chair of the Federal Reserve, ushering in the Fed’s "Warsh era."

Three Major Tailwinds Support Kospi to Surpass 8,000 Points for Record High; JPMorgan Backs Samsung: Any Pullback Is a Buying Opportunity

Tradingkey - During the Asian morning session on May 15, the KOSPI opened lower but trended upward, briefly surpassing 8,000 points to hit a record high, reaching an intraday peak of 8,046.78 points. As of press time, the KOSPI had reversed to a 0.4% decline, trading at 7,949.71. Market analysis suggests three major tailwinds are supporting the upward trajectory of the South Korean stock market: tech giants continue to scale up capital expenditure, significant room remains for the expansion of AI application penetration, and geopolitical factors alongside data sovereignty are driving increased investment from non-US countries. Given the high weighting of AI-related industries among South Korean listed companies, these factors are expected to provide continued support for the market. Furthermore, corporate governance is poised to become a second structural support pillar by 2026, alongside earnings improvement. If companies continue to deliver on share buybacks and cancellations, dividend increases, asset efficiency optimization, and enhanced transparency in information disclosure, the market pricing of the "Korea Discount" is expected to narrow further, driving a valuation recovery for low P/B blue chips from a tactical phase into a sustained trend.

Today’s Market Recap: AI Rally Sends S&P 500, Nasdaq to Records; Nvidia Leads Surge

US markets hit records on AI growth and Nvidia’s China expansion. Key drivers include Cisco’s gains, Cerebras’ IPO, US-China diplomacy, South Korean retail FOMO, and Middle East tensions.

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools